CDTX vs PG
Cidara Therapeutics Inc (CDTX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
CDTX currently screens at market cap $6.96B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the CDTX and PG stock pages for the full models.
Not investment advice.